Status:
COMPLETED
Faecal Analyses in Rheumatoid Arthritis Therapy
Lead Sponsor:
Region Skane
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the intestinal microbiome and disease activity in patients with rheumatoid arthritis receiving immunosuppressive therapy. Patients will be analysed at two time points in reference...
Detailed Description
Methotrexate (MTX) and tumor necrosis factor (TNF) -inhibitors are two efficient medications for the treatment of rheumatoid arthritis. In a substantial number of cases however, these medications rema...
Eligibility Criteria
Inclusion
- Rheumatoid arthritis according to the 2010 classification criteria
- About to start methotrexate or TNF-inhibitor because of active disease
Exclusion
- Failure to understand protocol
- A history of alcohol abuse
- Concomitant inflammatory bowel disease
- Any history of diverticulitis
- A history of failure to comply with prescribed medication
- Ongoing biological therapy
Key Trial Info
Start Date :
August 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03775824
Start Date
August 1 2016
End Date
June 1 2019
Last Update
September 16 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.